Jessica Moore on Alzheimer's disease
From Dr. Jon LaPook talks about the latest developments in the fight against Alzheimer’s · · CBS New York
“Giving these medications before symptoms occur is a revolutionary approach, similar to prescribing statins after a heart attack rather than before. The idea of early intervention could transform how we manage Alzheimer's in the future.”
On , Jessica Moore, Former Vice President of Investor Relations at Johnson & Johnson, spoke about Alzheimer's disease during Dr. Jon LaPook talks about the latest developments in the fight against Alzheimer’s on CBS New York.
About Jessica Moore
Jessica Moore, formerly Vice President of Investor Relations at Johnson & Johnson, has been publicly sharing her personal journey of recovery from substance use. In an August 2025 interview, Moore stated that she has been in recovery since July 8, 2022, and described it as her only period of sobriety that was not court-ordered. She said she began using drugs at age 13 and that her motivation to stay clean increased with each milestone. Moore said she is currently pursuing a bachelor's degree to become a counselor, and that her goal is to help others as a peer recovery specialist, a role she learned about during her own treatment. Moore has also discussed her career in television news. In a 2017 interview, she recounted being told by a news director and executive producer that she did not have what it takes for a reporting job, a moment she described as devastating. She said the same man later sent her a congratulatory email after she achieved success. Moore advised that people should be willing to fail and that discouragement often comes from those who have not taken risks themselves.